Ifosfamide [clinicaltrials_resource:991b8d1d3c9a2d00b4fdd88a2bd43c5b]
A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [clinicaltrials:NCT00001300]Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer [clinicaltrials:NCT00002466]Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002546]clinicaltrials:NCT00002558Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [clinicaltrials:NCT00002559]Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma [clinicaltrials:NCT00002601]Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002641]Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer [clinicaltrials:NCT00002684]clinicaltrials:NCT00002804clinicaltrials:NCT00002816Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer [clinicaltrials:NCT00002822]clinicaltrials:NCT00002835High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002854]Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00003052]Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [clinicaltrials:NCT00003105]Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [clinicaltrials:NCT00003128]Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003198]Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [clinicaltrials:NCT00003212]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer [clinicaltrials:NCT00003284]S9624 Ifosfamide in Treating Patients With Meningeal Tumors [clinicaltrials:NCT00003292]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [clinicaltrials:NCT00003406]Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003575]Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003597]Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003657]Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00003683]clinicaltrials:NCT00003937Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer [clinicaltrials:NCT00003941]Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer [clinicaltrials:NCT00004077]clinicaltrials:NCT00004186Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery [clinicaltrials:NCT00004887]Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004916]clinicaltrials:NCT00005977Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00006032]Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00006260]clinicaltrials:NCT00006373clinicaltrials:NCT00006708clinicaltrials:NCT00006734clinicaltrials:NCT00006760
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Ifosfamide [clinicaltrials_resource:991b8d1d3c9a2d00b4fdd88a2bd43c5b]
Bio2RDF identifier
991b8d1d3c9a2d00b4fdd88a2bd43c5b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:991b8d1d3c9a2d00b4fdd88a2bd43c5b
identifier
clinicaltrials_resource:991b8d1d3c9a2d00b4fdd88a2bd43c5b
title
Ifosfamide
@en
type
label
Ifosfamide [clinicaltrials_resource:991b8d1d3c9a2d00b4fdd88a2bd43c5b]
@en